ARTICLE | Company News
Medigene, Aventis Pharma AG deal
February 22, 2000 8:00 AM UTC
AVE received an exclusive license as well as sublicensing rights to develop and commercialize MediGene’s vaccine to treat malignant melanoma in Europe, the U.S., Japan, Canada and other territories. M...